What are the guidelines for safely closing a hemodialysis session in patients with end-stage renal disease (ESRD) or acute kidney injury (AKI) to prevent complications such as hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Safely Closing a Hemodialysis Session

To safely close a hemodialysis session, immediately stop or reduce ultrafiltration and dialysate flow, decrease blood flow to 50-100 mL/min for 15 seconds to clear access recirculation, then draw the postdialysis blood sample using the slow flow/stop pump technique before returning blood and disconnecting the patient. 1

Critical End-of-Session Blood Sampling Protocol

The NKF-K/DOQI guidelines mandate a specific technique to ensure accurate measurement of delivered dialysis dose and prevent sampling errors that falsely inflate treatment adequacy 1:

Slow Flow/Stop Pump Sampling Technique

At treatment completion:

  • Turn off dialysate flow and decrease ultrafiltration rate to 50 mL/h or the lowest transmembrane pressure setting 1
  • If the machine does not allow turning off dialysate flow, decrease it to minimum setting 1
  • Decrease blood flow to 50-100 mL/min for 15 seconds to fill the arterial needle tubing with non-recirculated blood 1
  • Manually adjust venous pressure limits downward to prevent pump shut-off 1

Blood sample collection (choose one method):

  • Slow flow technique: With blood pump running at 50-100 mL/min, draw blood from the arterial sampling port closest to the patient 1
  • Stop pump technique: Immediately stop the blood pump, clamp arterial and venous blood lines, then draw blood from the arterial sampling port or directly from arterial needle tubing after disconnection 1

Critical timing: Blood must be drawn within 0.25-0.50 minutes after dialysis ends to avoid falsely elevated BUN from urea rebound, which begins immediately due to cardiopulmonary recirculation and compartment effects 1

Managing Hypotension During Session Closure

If hypotension occurs during the closing phase:

  • Stop or reduce ultrafiltration immediately to prevent further blood pressure decline 2, 3
  • Place patient in Trendelenburg position (head down, legs elevated) to improve venous return 2, 3
  • Administer supplemental oxygen to improve tissue oxygenation 2, 3
  • Consider intravenous normal saline bolus (100-250 mL) only if necessary, avoiding routine administration that perpetuates volume overload 2

Prevention of Common Closing-Phase Complications

Avoid premature discontinuation errors that reduce effective treatment time:

  • Do not terminate dialysis early for staff convenience or scheduling conflicts 1
  • Do not honor patient requests for early termination without medical justification 1
  • Account for all treatment interruptions (equipment alarms, needle manipulation, dialyzer clotting) when calculating actual dialysis time 1
  • Use synchronized dialysis unit clocks rather than wristwatches to measure treatment intervals 1

Safety Measures for Central Venous Catheter Patients

For patients with CVCs receiving intensive hemodialysis:

  • Use closed connector devices (InterLink, Tego, Swan-Lock) to prevent potentially fatal air embolism and bleeding during disconnection 1
  • Ensure proper connection technique, as improper use can paradoxically cause the complications these devices prevent 1
  • Provide assistance to patients with limited manual dexterity to ensure correct device usage 1

Documentation Requirements

Accurate time recording is essential:

  • Document exact initiation and termination times to calculate effective dialysis time 1
  • Record any interruptions during treatment that reduced actual dialysis time 1
  • Avoid clerical deficiencies that render effective dialysis time unknown 1
  • Wrong patient disconnection represents a critical safety error requiring verification protocols 1

Common Pitfalls to Avoid

Blood sampling errors that compromise adequacy assessment:

  • Never draw postdialysis BUN before dialysis ends, as this increases the measured BUN and falsely suggests inadequate dialysis 1
  • Never draw postdialysis BUN more than 5 minutes after dialysis, as urea rebound significantly elevates the value 1
  • Never draw predialysis BUN after starting dialysis, as this lowers the measured value through dilution and recirculation 1
  • Never dilute the predialysis sample with saline, which reduces true BUN concentration 1

Treatment time errors:

  • Do not calculate time incorrectly or read initiation/completion times inaccurately 1
  • Do not fail to account for dialysate bypass periods when conductivity or temperature alarms occur 1
  • Do not assume continuous treatment without verifying no interruptions occurred 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypotension in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hemodialysis Emergencies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the acute complications of hemodialysis and how are they managed?
What is the approach to managing dyspepsia in patients with End-Stage Renal Disease (ESRD) on hemodialysis?
What is the best approach to manage asthma in patients undergoing hemodialysis (HD) due to impaired renal function?
Can a patient with End-Stage Renal Disease (ESRD) receive Plasmalyte (balanced crystalloid solution) as an intraoperative fluid?
What are the immediate steps to take in the event of a dialysis shunt malfunction?
What is the appropriate diagnosis and treatment for a patient with symptoms such as numbness, tingling, or weakness in the ring and little fingers, as well as pain or discomfort in the elbow or wrist, who may have been misdiagnosed?
How do postoperative adhesions cause ileocecal (small intestine and colon) intussusception in a patient with a history of abdominal surgery?
What is the best management approach for a patient with a large hepatocellular carcinoma (HCC) and elevated bilirubin levels potentially due to tumor obstruction, with a Child-Pugh score of B7?
Does the brain have backup pathways to produce neurosteroids in a middle-aged to older male patient with a history of Benign Prostatic Hyperplasia (BPH) or androgenetic alopecia when 5-alpha-reductase (5AR) is inhibited by dutasteride (generic name: dutasteride)?
What alternative antihypertensive agents can be used for an elderly male patient with Alzheimer's disease, grade I diastolic dysfunction, and Chronic Kidney Disease (CKD) stage 3B, who is sensitive to Angiotensin Receptor Blockers (ARBs) and has a history of orthostatic hypotension?
What are some impactful topics for a poster or paper presentation in Obstetrics and Gynecology (OBGYN)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.